Saxenda is a brand-name injectable solution prescribed ... Saxenda should not be used during pregnancy. The drug hasn’t been studied in human pregnancy. When Saxenda was given to pregnant ...

said she hoped generic liraglutide’s price “will be significantly lower than name brand Victoza and Saxenda, but lessons from other drugs that are available as generics teach us that this ...

Novo Nordisk has won a Committee for Medicinal Products for Human Use (CHMP) endorsement for a higher-dose version of its diabetes drug liraglutide ... will be marketed as Saxenda, has been ...

Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) submitted a Citizen Petition to the FDA requesting the exclusion of liraglutide from the 503B Bulks List, a registry of substances that ...

Novo Nordisk’s Saxenda has been recommended by NICE as a treatment for obesity, ending a 10-year drought in new drug therapies for weight management. The cost-effectiveness agency for England ...

Complicating the issue for Novo, generic drug makers and compounders, however, is the fact that certain doses of Victoza and Saxenda are currently ... marketed under the brand names Mounjaro ...

A drug approved to treat obesity in adults ... It’s taken as a daily injection and is approved under the brand name Victoza to treat diabetes in adults and children ages 10 and older and as Saxenda to ...

Liraglutide, sold under the brand name Victoza for diabetes ... liraglutide approved for obesity, called Saxenda. “There are many people on this drug, and they will benefit by another generic ...

Also Read: Novo Nordisk’s Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows Novo Nordisk asserts that compounded liraglutide products have a ...